204 related articles for article (PubMed ID: 21717070)
41. Increased phosphorylation of the carboxyl-terminal domain of RNA polymerase II and loading of polyadenylation and cotranscriptional factors contribute to regulation of the ig heavy chain mRNA in plasma cells.
Shell SA; Martincic K; Tran J; Milcarek C
J Immunol; 2007 Dec; 179(11):7663-73. PubMed ID: 18025212
[TBL] [Abstract][Full Text] [Related]
42. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
[TBL] [Abstract][Full Text] [Related]
43. IL-3 induces inhibitor of DNA-binding protein-1 in hemopoietic progenitor cells and promotes myeloid cell development.
Leeanansaksiri W; Wang H; Gooya JM; Renn K; Abshari M; Tsai S; Keller JR
J Immunol; 2005 Jun; 174(11):7014-21. PubMed ID: 15905544
[TBL] [Abstract][Full Text] [Related]
44. Identification of B cells in multilineage hematopoietic colonies derived from cells of patients with lymphocytic lymphoma.
Fauser AA; Kanz L; Löhr GW
Proc Natl Acad Sci U S A; 1985 Feb; 82(3):883-5. PubMed ID: 3883349
[TBL] [Abstract][Full Text] [Related]
45. Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow.
Kojima H; Kobayashi A; Sakurai D; Kanno Y; Hase H; Takahashi R; Totsuka Y; Semenza GL; Sitkovsky MV; Kobata T
J Immunol; 2010 Jan; 184(1):154-63. PubMed ID: 19949104
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional activation of vesicular monoamine transporter 2 in the pre-B cell line Ea3.123.
Watson F; Deavall DG; Macro JA; Kiernan R; Dimaline R
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):193-9. PubMed ID: 9882615
[TBL] [Abstract][Full Text] [Related]
47. A novel stromal cell-dependent B lymphoid stem-like cell line that induces immunoglobulin gene rearrangement.
Matsuda K; Koguma M; Okuyama R; Nakazawa T; Matsuzaki Y; Nakauchi H; Yanai N; Terasaki T; Obinata M
J Biochem; 1999 Mar; 125(3):602-12. PubMed ID: 10050050
[TBL] [Abstract][Full Text] [Related]
48. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1.
Oguro H; Yuan J; Ichikawa H; Ikawa T; Yamazaki S; Kawamoto H; Nakauchi H; Iwama A
Cell Stem Cell; 2010 Mar; 6(3):279-86. PubMed ID: 20207230
[TBL] [Abstract][Full Text] [Related]
49. Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47.
Teachenor R; Beck K; Wright LY; Shen Z; Briggs SP; Murre C
Mol Cell Biol; 2012 May; 32(9):1671-82. PubMed ID: 22354994
[TBL] [Abstract][Full Text] [Related]
50. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
51. Increased expression of PcG protein YY1 negatively regulates B cell development while allowing accumulation of myeloid cells and LT-HSC cells.
Pan X; Jones M; Jiang J; Zaprazna K; Yu D; Pear W; Maillard I; Atchison ML
PLoS One; 2012; 7(1):e30656. PubMed ID: 22292011
[TBL] [Abstract][Full Text] [Related]
52. Transcription elongation factor S-II is required for definitive hematopoiesis.
Ito T; Arimitsu N; Takeuchi M; Kawamura N; Nagata M; Saso K; Akimitsu N; Hamamoto H; Natori S; Miyajima A; Sekimizu K
Mol Cell Biol; 2006 Apr; 26(8):3194-203. PubMed ID: 16581793
[TBL] [Abstract][Full Text] [Related]
53. The chemokine CXCL12 and regulation of HSC and B lymphocyte development in the bone marrow niche.
Nagasawa T
Adv Exp Med Biol; 2007; 602():69-75. PubMed ID: 17966390
[TBL] [Abstract][Full Text] [Related]
54. RNA polymerase II pausing modulates hematopoietic stem cell emergence in zebrafish.
Yang Q; Liu X; Zhou T; Cook J; Nguyen K; Bai X
Blood; 2016 Sep; 128(13):1701-10. PubMed ID: 27520065
[TBL] [Abstract][Full Text] [Related]
55. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
[TBL] [Abstract][Full Text] [Related]
56. Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors.
Akala OO; Park IK; Qian D; Pihalja M; Becker MW; Clarke MF
Nature; 2008 May; 453(7192):228-32. PubMed ID: 18418377
[TBL] [Abstract][Full Text] [Related]
57. The super elongation complex family of RNA polymerase II elongation factors: gene target specificity and transcriptional output.
Luo Z; Lin C; Guest E; Garrett AS; Mohaghegh N; Swanson S; Marshall S; Florens L; Washburn MP; Shilatifard A
Mol Cell Biol; 2012 Jul; 32(13):2608-17. PubMed ID: 22547686
[TBL] [Abstract][Full Text] [Related]
58. Plasma cell formation, secretion, and persistence: the short and the long of it.
Bayles I; Milcarek C
Crit Rev Immunol; 2014; 34(6):481-99. PubMed ID: 25597311
[TBL] [Abstract][Full Text] [Related]
59. The RNA Pol II elongation factor Ell3 marks enhancers in ES cells and primes future gene activation.
Lin C; Garruss AS; Luo Z; Guo F; Shilatifard A
Cell; 2013 Jan; 152(1-2):144-56. PubMed ID: 23273992
[TBL] [Abstract][Full Text] [Related]
60. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
